Table 4.
Multivariable regression analysis of factors associated with postoperative complications
| Any complicationsa (aOR, 95% CI) |
p value | Major complicationsb (aOR, 95% CI) |
p value | Minor complicationsc (aOR, 95% CI) |
p value | |
|---|---|---|---|---|---|---|
| Lower BMIb | Reference | Reference | Reference | |||
| Higher BMI | 1.06 (1.01–1.10) | 0.017 | 0.96 (0.88–1.04) | 0.320 | 1.13 (1.07–1.19) | < 0.001 |
| BMI groups | ||||||
| Normal BMI (18.5–24.9) | Reference | Reference | Reference | |||
| Underweight (< 18.5) | 1.04 (0.82–1.32) | 0.748 | 0.93 (0.67–1.30) | 0.670 | 1.18 (0.89–1.56) | 0.242 |
| Overweight (25–29.9) | 0.97 (0.92–1.02) | 0.219 | 0.87 (0.80–0.93) | < 0.001 | 1.02 (0.96–1.09) | 0.547 |
| Obesity Class 1 (30–34.9) | 0.94 (0.89–1.00) | 0.050 | 0.84 (0.77–0.91) | < 0.001 | 1.01 (0.94–1.09) | 0.761 |
| Obesity Class 2 (35–39.9) | 1.01 (0.95–1.08) | 0.764 | 0.82 (0.75–0.90) | < 0.001 | 1.12 (1.03–1.21) | 0.006 |
| Obesity Class 3 (≥ 40.0) | 1.04 (0.97–1.12) | 0.316 | 0.83 (0.75–0.91) | < 0.001 | 1.17 (1.08–1.28) | < 0.001 |
BMI, body mass index
aAdjusted for: age, race, ethnicity, tobacco use, diabetes, chronic hypertension, immunosuppressive therapy, chronic obstructive pulmonary disease, ASA classification III/IV, preoperative blood transfusion, surgical indication, hysterectomy type, uterine weight, concomitant surgical procedures
bAdjusted for: age, race, tobacco use, diabetes, chronic hypertension, immunosuppressive therapy, chronic obstructive pulmonary disease, ASA classification III/IV, preoperative blood transfusion, surgical indication, hysterectomy type, uterine weight, concomitant surgical procedures
cKolmogorov–Smirnov test—any complications—35.0, major complications—39.44, minor complication—35.16